The release of CD69 (Figures 4A, B; Supplementary Figure 5A) and CD107a (Figure 4C) in the armored-T cells was significantly increased, when compared with the CON-T cells, indicating that the activation potential of armored-T cells was higher when stimulated with tumor cells and antibody than that of CON-T cells. The gene discussed is LAMP1; the disease is neoplasm.